
According to Benzinga Pro, during Q4, Voyager Therapeutics (NASDAQ:VYGR) earned $5.71 million, a 122.71% increase from the preceding quarter. Voyager Therapeutics also posted a total of $28.07 million in sales, a 1771.53% increase since Q3. Voyager Therapeutics collected $1.50 million in revenue during Q3, but reported earnings showed a $25.14 million loss.